Buyer: Quad-C Management
Seller: Pharm-Olam International
Sector: Clinical Research Organization
Pharm-Olam International Has Been Acquired by Quad-C Management. This transaction closed on February 1, 2017. Pharm-Olam International is a leading clinical contract research organization (CRO) providing full-service solutions to help clients successfully manage and advance their clinical trials. Based in Houston, TX, and with offices worldwide, Pharm-Olam has a track record of supporting global clinical trials in more than 60 countries. Pharm-Olam has experience in all clinical phases with a focus on Phase II and Phase III global trials. Its expertise covers a wide range of therapeutic areas and major indications, addressing complex, high-growth areas such as oncology, infectious diseases, endocrinology, and orphan indications.Founded in 1989 and based in Charlottesville, Virginia, Quad-C is a middle-market private equity firm focused on investing in well-established business services, consumer, general industrial, healthcare, specialty distribution, and transportation and logistics companies. In its 25-year history, the company has invested over $2 billion of equity across more than 50 companies. The Quad-C team is committed to partnering with entrepreneurs and management teams to accelerate growth and create long-term value.